London, May 16, 2026, 23:03 (BST)
Tate & Lyle will open Monday as a bid stock after shares jumped to 536p at Friday’s close, up about 45% from 370.8p the week before. London’s market is shut over the weekend. The rally followed news of U.S. peer Ingredion making an approach.
Ingredion’s latest offer puts Tate & Lyle at as much as 615p a share. Tate & Lyle stock still trades about 15% under that level. The difference is the bid spread, the discount in the market when there’s a risk the deal could fall through, be repriced, or drag out.
Tate & Lyle said it’s offering shareholders 595p in cash and the chance to get up to 20p more in dividends. That breaks down into a possible final dividend of up to 13p and an interim payment up to 7p. The board and Ingredion are talking, but the company said there’s “no certainty” an offer will happen. Tate & Lyle
Ingredion says it’s still in talks and doing due diligence. The UK Takeover Code gives it until 5 p.m. London time on June 11 to either make a binding offer or step back—a so-called “put up or shut up” deadline in London deals. SEC
FTSE 100 posted its worst one-day loss in over eight weeks on Friday, Reuters said. The tape was weak. The FTSE 250 mid-cap index dropped 1%. Both benchmarks ended the week in the red as political concerns, higher oil prices and inflation jitters pressured UK assets.
Barclays analyst Alex Sloane told the Financial Times there’s “significant overlap” between Ingredion and Tate & Lyle, mostly in sweeteners and starches. The overlap could mean cost savings but also more scrutiny, Sloane said. Financial Times
Tate & Lyle jumped up to 55% after Reuters reported the takeover talks, but Ingredion investors were less eager, with the stock slipping 2.8%. The same report said the combined company could be worth $10 billion.
Tate & Lyle has moved away from its sugar refiner roots. The Reuters company profile now calls it a specialty food and beverage ingredients company, with products like sweeteners, fibres, stabilisers, hydrocolloids, and starches sold in the Americas, EMEA, and Asia Pacific.
There’s still risk here. The offer is not binding. If due diligence finds anything, or if the two sides can’t agree, or regulators see too much overlap, the shares could lose some of the deal premium. The stock might trade again on fundamentals like demand, margins, and integration instead of takeover math.
Tate & Lyle faces another test next week as it reports fiscal 2026 results on May 21. CEO Nick Hampton and CFO Sarah Kuijlaars will present at 0930 BST. Investors are watching for updates on the bid, the CP Kelco deal, top-line growth, and the dividend plan.
Friday’s close points to the market seeing a deal as possible, but not finished yet. That’s a narrow difference, but it matters.
